A Philadelphia procurement manager is ready to order 300 sealed hand-cream tubes for a winter employee thank-you. The supplier's copy describes moisturizing skin, but the agency's sleeve says “heals workplace eczema.” Price and quantity are approved; printing has not started. The useful next decision is to hold that artwork, identify the new treatment promise and resolve it before the company's branding reaches the finished gift.

For US hand-cream corporate gifts, review the exact product and every added promise together. This guide helps procurement and People Operations separate supplier product wording, brand messages and claims that need a different specialist review. Two worked decisions show how to compare cost, timing and alternatives without treating a purchase order, attractive proof or familiar tube shape as product approval.
Start with the finished product and its intended use
Identify the commercial product before writing the sleeve. Record the supplier, exact SKU, pack size, destination, current packaging images and the version of the description being offered. Ask who can answer product classification and labeling questions for that item. A photograph of a similar cream or a distributor's general catalog page does not establish the details of the tubes that will arrive.
Keep the scope narrow: finished, sealed products with separately added company artwork. Opening, decanting, reformulating or relabeling the product creates questions beyond a routine thank-you sleeve. If the project changes in one of those ways, stop using the original scope as its approval basis. The person responsible for product review must decide what new evidence and responsibilities are needed.
FDA's Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?) explains that intended use determines the distinction. It identifies skin moisturizers among cosmetics and explains that treatment or disease-prevention claims can establish drug intended use. Claims in advertising, online material and other promotion can matter, alongside product labeling. A buyer's added campaign language therefore deserves review with the product's existing presentation.
This is a reason to route the actual promise, not a shortcut to classifying every cream. A supplier might offer a product with a properly reviewed therapeutic use. Another might offer an ordinary cosmetic moisturizer. Ask for the basis applicable to the specific product and US destination instead of deciding from its price, ingredient reputation or whether it comes from a well-known brand.
The appreciation program should also remain an appreciation program. Do not ask employees to disclose a skin condition to receive a routine gift or frame the cream as treatment the employer has selected for them. Provide an ordinary way to choose another appropriate item when the program allows it. A fragrance preference, a medical question and a product-claim review are separate decisions.
Map every promise before approving the sleeve
Collect the supplier's current product description and compare it with the proposed sleeve, insert, event invitation, employee-store listing and message sent to recipients. A treatment phrase removed from the sleeve can survive in a thumbnail or a copied email subject. Give each surface an owner and a disposition so “the copy was fixed” points to actual revisions rather than a meeting memory.
Use full phrases and relevant context. “For hardworking hands” and a claim to heal a named skin condition do not make the same promise. Images can change how words are understood, too. A medical symbol, a before-and-after panel or a testimonial may introduce an implication that the neutral headline alone does not show. Have the qualified reviewer consider the assembled message rather than approving isolated keywords.
| Surface | Proposed claim or message | Evidence owner | Disposition before release |
|---|---|---|---|
| Supplier's finished tube | Exact current product description | Supplier's product reviewer | Match the offered SKU and US-market packaging |
| Company sleeve | Heals workplace eczema | People Operations copy owner and qualified product reviewer | HOLD the unsupported treatment wording |
| Replacement sleeve proof | A thank-you for everything you do | Brand owner and product reviewer | Review the message with the assembled package |
| Employee-store page and invitation | Product description copied from approved source | Store and campaign owners | Check wording, images and current product version |
| Insert and support contact | Approved instructions and a route for product questions | Supplier and program support owner | Keep consistent with the actual item; resolve unanswered questions |
The neutral replacement in this table is a proposed brand message, not universal permission to release any hand cream. Product identity, applicable labeling and the assembled package still need review. Keep the product description distinct from the company's expression of thanks. That separation makes it easier to change a campaign greeting without quietly rewriting what the product is represented to do.
Record one of three useful dispositions for each disputed phrase: retain within the confirmed product scope, revise and return for review, or hold pending evidence. A missing answer is not approval. Identify which owner must provide the answer and the point after which printing cannot proceed. The printer should receive the released revision only, with the earlier rejected proof clearly superseded.
Recognize when cosmetic copy needs another review path
FDA's Cosmetics Labeling Claims says cosmetic claims must be truthful and not misleading and that FDA does not maintain a list of approved cosmetic claims. The absence of premarket cosmetic-label approval is not permission to invent a benefit. The review must connect the wording to the product and the applicable requirements rather than looking for a generic official badge.
“Heals workplace eczema” is a treatment promise that should not be added casually to a moisturizer campaign. The Philadelphia buyer does not need to diagnose an employee or determine whether the formula could ever have a therapeutic use. The immediate control is to stop the unreviewed artwork and ask the responsible specialists to assess the actual product and proposed representation.
Sun protection creates another important branch. FDA's classification explanation identifies moisturizers marketed with sun-protection claims as products that can be both cosmetics and drugs. A substitute advertising SPF therefore cannot inherit an approval limited to the original ordinary moisturizer. It may be an appropriate product after the relevant review; the buyer should not erase its identity or drug-related information to make the gift look simpler.
Avoid replacing one unsupported promise with a softer-sounding claim that still needs evidence. “Clinically proven,” “safe for everyone” or a universal suitability statement is not an automatic fallback. Ask what the words mean for the particular item and who supports them. A thank-you message can be more useful than a benefit the program cannot substantiate, but even neutral branding must fit the final package.
Keep broader obligations with the appropriate owner. FDA's MoCRA overview describes responsibilities including safety substantiation, facility registration and product listing, with applicability and exemptions requiring their own assessment. This artwork review does not determine those obligations or state-specific requirements. Ask the supplier and qualified reviewer to confirm the actual supply arrangement, including who is identified on the label.
Review the assembled gift, not just the flat artwork
FDA's Cosmetics Labeling Guide addresses placement, prominence, identity, quantity and ingredient-labeling questions. Use it as a reference for the supplier's reviewer, not as a replacement for checking the exact package. A sleeve can look clear on a screen while covering information or changing the presentation once wrapped around a small tube or carton.
Do not assume that a giveaway or a small container has a blanket labeling exemption. The guide distinguishes particular free-sample and retail circumstances in its discussion of ingredient declarations. The reviewer must determine the applicable treatment of this product and distribution arrangement. The purchasing team should provide the facts and request a documented answer rather than treating “not for resale” as a universal solution.
Ask for a physical assembled sample or another review method that genuinely establishes placement, access and readability for the final configuration. Check the front, back, folds, overlap and the way recipients open it. Keep the original tube sealed. If the added material hides information that the reviewer says must remain available in the required way, hold the assembly and resolve its design before authorizing a run.
A loose insert is not automatically a lawful replacement for information covered by a sleeve. Nor does a QR code automatically cure a packaging problem. Have the product reviewer decide whether the proposed arrangement meets the requirements that apply. Keep the exact answer with the actual product and proof; a general statement that the supplier “does this all the time” leaves the buyer without a decision it can trace.
Check consistency across the order packet. The purchase order, sample, supplier confirmation and printable sleeve should identify the same product size and version. If the factory or distributor proposes a change after approval, reopen the affected review. The company's logo is not evidence that the product beneath it is unchanged, and a correct color proof does not establish the accuracy of its claims.
Philadelphia decision: hold the treatment promise before 300 sleeves
Assume the supplier confirms the exact finished cosmetic moisturizer and its existing description, while the company's new sleeve adds the eczema-healing phrase. The 300 tubes remain sealed and printing has not begun. Procurement has a fixed event date and an approved product budget. The buyer's immediate choice concerns the added copy, not reformulating the cream or asserting a therapeutic outcome.
The lead places the sleeve artwork on hold, collects the matching campaign surfaces and requests the supplier's product review. The revised brand message expresses thanks without adding the treatment promise. The product reviewer then checks that replacement with the finished packaging and approved product wording. The store page, insert and recipient invitation receive the same controlled correction where relevant.
For a budget comparison, assume 300 tubes cost $4.80 each, 300 sleeves cost $0.65 each and setup costs $85. Product cost is 300×$4.80=$1,440; sleeves cost 300×$0.65=$195. The planned total is $1,440+$195+$85=$1,720, excluding tax and freight. These are assumed quote inputs for comparing the decision, not market prices or a claim about a particular supplier.
Suppose correcting the proof before printing adds a quoted $60 artwork charge. The revised total is $1,780, an increase of $60÷300=$0.20 per intended gift. If all sleeves had already been printed, a complete replacement at the same unit price plus a new $85 setup would instead add $280 before any handling or disposal. The difference is $220 in these two stated scenarios; neither amount prices the consequences of distributing unsupported claims.
Timing needs a separate check. Assume five business days remain before print release, the responsible reviewer needs two days, a revised assembled proof needs one day and final owner review needs one day. Sequential work totals four business days, leaving one day of planned margin. Confirm dependencies and actual availability; a correction requiring another two-day cycle would exceed that window by one day.
If the review cannot close in time, do not print the disputed sleeve to protect the event date. Consider an already accepted unbranded configuration or a separately reviewed alternative, with its own commercial consequences. Acceptance requires the exact cream, final message, assembled proof and every affected campaign surface to agree. The rejected treatment copy and dated replacement decision stay in the record even when the quantity remains 300.
Austin decision: an SPF substitute needs its own evidence
Assume an Austin People Operations team needs 120 gifts in ten business days. Its preferred ordinary moisturizer is unavailable. A supplier offers a similar-looking SPF hand product, while an already reviewed notebook is also available. The buyer holds approval only for the original moisturizer. The tube shape and “premium” description do not establish that the substitute fits the same product and wording review.
Compare three paths: wait for the original, complete the substitute's relevant product-specific review, or use the notebook. Ask for the exact substitute SKU, current US packaging, intended-use information and the qualified reviewer responsible for its requirements. Do not copy the old cosmetic description onto the SPF product or assume that excluding the SPF phrase from the company's sleeve changes what the offered product is.
| Route | Assumed commercial inputs | Evidence needed | Decision at the release deadline |
|---|---|---|---|
| Wait for original moisturizer | 120 units; supplier quotes 14 business days | Confirmed original product and renewed delivery commitment | Does not meet the ten-day event plan under this quote |
| Review SPF substitute | $6.20 product plus $0.70 sleeve per gift; $90 setup | Exact product, relevant requirements, wording and assembled proof | HOLD if review remains incomplete |
| Use accepted notebook | $5.10 product plus $0.40 band per gift; $60 setup | Current accepted SKU, final band and confirmed supply | Proceed only within its own accepted scope and schedule |
The SPF route costs 120×($6.20+$0.70)+$90=$918 under these assumptions. The notebook route costs 120×($5.10+$0.40)+$60=$720. The difference is $198 total, or $1.65 per gift. Tax and freight are excluded from both, so confirm those terms before treating the comparison as a landed-cost decision. A lower price does not settle whether the product evidence is complete.
Assume the proposed SPF route needs four business days for the relevant review, two for the assembled proof and five for production and delivery, with these stages sequential. That is eleven business days, one beyond the ten-day window. The notebook's confirmed plan allows one day for band review and six for production and delivery: seven days, leaving three. These are planning allowances that require actual commitments, not regulatory-review or shipping guarantees.
If the SPF review remains incomplete at the agreed release deadline, choose the accepted notebook path and update the gift description and order packet. The SPF product is not declared universally unsuitable; it stays a candidate for a future program after its own review. If the notebook supply or proof changes, reopen that route too. An alternative is useful only when its accepted scope and delivery plan remain real.
Release evidence should identify exactly what was accepted
Keep a compact release packet: product and size identifiers, destination, supplier product-review contact, applicable intended-use decision, current product images, approved copy, assembled proof, quantity, delivery terms and the people who accepted each part. Separate a budget authorization from a product review and a print release. The same approver may act twice, but its decisions should not be merged into one ambiguous signature.
Use an explicit hold when an answer is missing: HOLD — do not release the affected artwork or substitute until its product-specific review and assembled-package decision are complete. State what evidence closes the hold and who can accept it. A deadline passing does not convert it into permission, and a procurement receipt does not establish that a different branded proof was accepted.
At receiving, compare the delivered product and added packaging with the released configuration under the agreed inspection plan. If a size, product description or sleeve revision differs, separate the affected units and ask the responsible owners for disposition. An intact seal does not settle a claim mismatch. Record whether units are held, corrected, replaced or accepted with an authorized, supportable change rather than distributing them while the question is unresolved.
Keep recipient support practical. Tell the program team where product questions and complaints should go, without turning a workplace gift desk into a diagnostic service. A report of a reaction needs the supplier's and organization's appropriate response process; an event organizer should not reassure a recipient that the cream is universally harmless. Preserve product identification and relevant records while limiting unnecessary collection of personal health information.
Reopen the review when the formulation, product name, pack size, supplier, wording, sleeve, destination or relevant authority changes. Check the actual offered item before each reorder. A previous acceptance may be useful evidence for an unchanged configuration, but it cannot establish the facts of a substitute the reviewer has never seen. Assign ownership for refreshing sources and record the version used for the next decision.
Bring Giftpack an approved product and branding scope
Take the accepted item specification, supplier-approved description, final brand files, quantity, destination and fulfillment requirements to Giftpack's custom merchandise team. Its documented service scope includes product and packaging development, sampling, manufacturing coordination, quality checks, packing and delivery around approved specifications. Confirm which work is available for the actual program and which product decisions remain with the supplier and qualified reviewers.
The published Giftpack product-specification and acceptance guide provides a related way to connect supplier evidence, approved samples and receiving decisions. Use that discipline to keep the cream and sleeve versions together. The Giftpack Help Center explains merchandise and fulfillment support; it is not a cosmetic classification service, medical adviser or automatic approver of regulatory claims.
The Philadelphia manager can now release a reviewed thank-you message instead of an unreviewed eczema promise. The Austin team can meet its accepted plan with the notebook while keeping the SPF candidate on a separate review path. In both cases, branding follows a documented product decision, and the handoff tells each partner exactly which item, words and assembled package it is being asked to produce.

